Ex-Roche head Franz Humer joins Portuguese board

By Fiona BARRY

03-Feb-2015 - Last updated on 03-Feb-2015 at 11:59 GMT

Nabriva Therapeutics

Schedule your appointment

Related tags Middle east

Follow us

Products

View more

Webinars

On-demand webinars

Headlines

PCI Pharma initiates installation of $100M isolator-based sterile fill-finish site
Walgreens to be used as clinical trial sites focusing on obesity and type 2 diabetes
Displaid's heart tech, liberation from the constraints of traditional monitoring?
Organon a spin off from Merck & Co leading the way for women's health in Montreal and beyond
UK health offers course for professionals to learn from the forefront of psychedelic research hub
Could AI signal the end of the use of lab rats in research? Olden Labs reveals all
Lonza integrates advanced technology to simplify synthetic route identification for novel APIs
AFX Medical's aspiring AI technology transforms brain lesion detection in radiation oncology
Owlstone Medical's $6.5M funding from investors and Bill and Melinda Gates Foundation
Has Response Pharmacauticals won the fight against antipsychotic weight gain?
Interview: Is global AI regulation really revolutionizing pharma and clinical trials?